FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Börse Stuttgart 13:56:04 2024-06-26 EDT | ||
| 1.74 EUR | +2.96% |
|
| Current month | +17.57% | ||
| 1 month | +10.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 1.74 | +2.96% |
| 24-06-25 | 1.69 | +0.60% |
| 24-06-24 | 1.68 | +5.66% |
| 24-06-21 | 1.59 | +11.19% |
| 24-06-20 | 1.43 | +0.70% |
Delayed Quote Börse Stuttgart
Last update June 26, 2024 at 01:56 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Morgan Stanley |
| WKN | ME3HJR |
| ISIN | DE000ME3HJR3 |
| Date issued | 2023-11-13 |
| Strike | 35.42 $ |
| Maturity | Unlimited |
| Parity | 3.79 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.71 € |
|---|---|
| Lowest since issue | 1.27 € |
| Spread | 0.1 € |
| Spread % | 5.59% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.51
USD
Average target price
53.19
USD
Spread / Average Target
+28.15%
- Stock Market
- Certificates
- Certificat
